Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Schuetz, Philipp ^a   Stolz, Daiana ^a   Mueller, Beat ^a   Morgenthaler, Nils G ^b   Struck, Joachim ^b   Mueller, Christian ^a   Bingisser, Roland ^a   Tamm, Michael ^a   Christ Crain, Mirjam ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BRAHMS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1; PROCALCITONIN; PROENDOTHELIN 1; PROTEIN PRECURSOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; BLOOD; COMMUNICABLE DISEASE; HOSPITALIZATION; IMMUNOASSAY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; STATISTICAL MODEL; SWITZERLAND; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; ENDOTHELIN-1; FEMALE; HUMANS; IMMUNOASSAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PROGNOSIS; PROTEIN PRECURSORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; ROC CURVE; SEVERITY OF ILLNESS INDEX; SWITZERLAND; TREATMENT OUTCOME;

EID: 42649118851     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-22     Document Type: Article

References (38)

1. Wanecek M Weitzberg E Rudehill A Oldner A The endothelin system in septic and endotoxin shock Eur J Pharmacol 2000, 407:1-15. 10.1016/ S0014-2999(00)00675-0 11050285
2. Shah R Endothelins in health and disease Eur J Intern Med 2007, 18:272-282. 10.1016/j.ejim.2007.04.002 17574100
3. Hemsen A Modin A Weitzberg E Increased concentrations of endothelin-1 messenger RNA in tissues and endothelin-1 peptide in plasma in septic pigs: Modulation by betamethasone Crit Care Med 1996, 24:1530-1536. 10.1097/00003246-199609000-00017 8797627
4. Brauner JS Rohde LE Clausell N Circulating endothelin-1 and tumor necrosis factor-alpha: Early predictors of mortality in patients with septic shock Intensive Care Med 2000, 26:305-313. 10.1007/s001340051154 10823387
5. Tschaikowsky K Sagner S Lehnert N Kaul M Ritter J Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines Crit Care Med 2000, 28:1854-1860. 10.1097/00003246-200006000-00028 10890632
6. Wanecek M Oldner A Sundin P Alving K Weitzberg E Rudehill A Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock Eur J Pharmacol 1999, 386:235-245. 10.1016/S0014-2999(99)00774-8 10618475
7. Krejci V Hiltebrand LB Erni D Sigurdsson GH Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock Crit Care Med 2003, 31:203-210. 10.1097/ 00003246-200301000-00031 12545016
8. Oldner A Wanecek M Goiny M Weitzberg E Rudehill A Alving K Sollevi A The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock Gut 1998, 42:696-702. 1727119 9659167
9. Iskit AB Senel I Sokmensuer C Guc MO Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock Eur J Pharmacol 2004, 506:83-88. 10.1016/ j.ejphar.2004.10.038 15588628
10. Struck J Morgenthaler NG Bergmann A Proteolytic processing pattern of the endothelin-1 precursor in vivo Peptides 2005.
11. Papassotiriou J Morgenthaler NG Struck J Alonso C Bergmann A Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma Clin Chem 2006, 52:1144-1151. 10.1373/ clinchem.2005.065581 16627560
12. Schuetz P Christ-Crain M Morgenthaler NG Struck J Bergmann A Muller B Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis Endothelium 2007, 14:345-351. 10.1080/10623320701678326 18080871
13. Christ-Crain M Stolz D Bingisser R Muller C Miedinger D Huber PR Zimmerli W Harbarth S Tamm M Muller B Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial Am J Respir Crit Care Med 2006, 174:84-93. 10.1164/rccm.200512-1922OC 16603606
14. Fine MJ Auble TE Yealy DM Hanusa BH Weissfeld LA Singer DE Coley CM Marrie TJ Kapoor WN A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997, 336:243-250. 10.1056/ NEJM199701233360402 8995086
15. Lim WS van der Eerden MM Laing R Boersma WG Karalus N Town GI Lewis SA Macfarlane JT Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study Thorax 2003, 58:377-382. 10.1136/thorax.58.5.377 12728155 1746657
16. Niederman MS Bass JB Jr Campbell GD Fein AM Grossman RF Mandell LA Marrie TJ Sarosi GA Torres A Yu VL Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association Am Rev Respir Dis 1993, 148:1418-1426. 8239186
17. Mortensen EM Coley CM Singer DE Marrie TJ Obrosky DS Kapoor WN Fine MJ Causes of death for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study Arch Intern Med 2002, 162:1059-1064. 10.1001/archinte.162.9.1059 11996618
18. Grandel U Grimminger F Endothelial responses to bacterial toxins in sepsis Crit Rev Immunol 2003, 23:267-299. 10.1615/ CritRevImmunol.v23.i4.20 14700271
19. Kedzierski RM Yanagisawa M Endothelin system: The double-edged sword in health and disease Annu Rev Pharmacol Toxicol 2001, 41:851-876. 10.1146/ annurev.pharmtox.41.1.851 11264479
20. Sanai L Haynes WG MacKenzie A Grant IS Webb DJ Endothelin production in sepsis and the adult respiratory distress syndrome Intensive Care Med 1996, 22:52-56. 10.1007/BF01728331 8857438
21. Voerman HJ Stehouwer CD van Kamp GJ Strack van Schijndel RJ Groeneveld AB Thijs LG Plasma endothelin levels are increased during septic shock Crit Care Med 1992, 20:1097-1101. 10.1097/00003246-199208000-00005 1643888
22. Prat C Dominguez J Andreo F Blanco S Pallares A Cuchillo F Ramil C Ruiz-Manzano J Ausina V Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect 2006, 52:169-177. 10.1016/ j.jinf.2005.05.019 16026842
23. Masia M Gutierrez F Shum C Padilla S Navarro JC Flores E Hernandez I Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index Chest 2005, 128:2223-2229. 10.1378/chest.128.4.2223 16236878
24. Ahlborg G Weitzberg E Lundberg JM Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans J Appl Physiol 1995, 79:141-145. 7559211
25. Weitzberg E Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation Acta Physiol Scand Suppl 1993, 611:1-72. 8379340
26. Weitzberg E Lundberg JM Rudehill A Elevated plasma levels of endothelin in patients with sepsis syndrome Circ Shock 1991, 33:222-227. 2065442
27. Ramalho FS Fernandez-Monteiro I Rosello-Catafau J Peralta C Hepatic microcirculatory failure Acta Cir Bras 2006, 21(Suppl 1):48-53. 17013514
28. Marshall JC Biomarkers of Sepsis Curr Infect Dis Rep 2006, 8:351-357. 10.1007/s11908-006-0045-1 16934193
29. Vincent JL Wendon J Groeneveld J Marshall JC Streat S Carlet J The PIRO concept: O is for organ dysfunction Crit Care 2003, 7:260-264. 270690 12793882 10.1186/cc2196
30. Wanecek M Weitzberg E Alving K Rudehill A Oldner A Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock Acta Anaesthesiol Scand 2001, 45:1262-1270. 10.1034/j.1399-6576.2001.451015.x 11736680
31. Weitzberg E Hemsen A Rudehill A Modin A Wanecek M Lundberg JM Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock Br J Pharmacol 1996, 118:617-626. 1909693 8762086
32. Christ-Crain M Morgenthaler NG Stolz D Muller C Bingisser R Harbarth S Tamm M Struck J Bergmann A Muller B Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] Crit Care 2006, 10:R96. 1550935 16805922 10.1186/cc4443
33. Christ-Crain M Morgenthaler NG Struck J Harbarth S Bergmann A Muller B Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study Crit Care 2005, 9:R816-824. 1414007 16356231 10.1186/ cc3885
34. Christ-Crain M Morgenthaler NG Struck J Bergmann A Mueller B Copeptin in critically ill patients - an observational study Endocrine Society Boston, USA 2006.
35. Mueller B Morgenthaler NG Stolz D Schuetz P Mueller C Bingisser R Bergmann A Tamm M Christ-Crain M Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections Eur J Clin Invest 2007.
36. Mueller B Sueess E Schuetz P Mueller C Bingisser R Bergmann A Stolz D Tamm M Morgenthaler NG Christ-Carin M Circulating levels of Pro-Atrial Natriuretic Peptide in Lower Respiratory Tract Infections J Int Med 2006.
37. Mueller C Laule-Kilian K Frana B Rodriguez D Scholer A Schindler C Perruchoud AP Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease Am Heart J 2006, 151:471-477. 10.1016/j.ahj.2005.03.036 16442916
38. Mueller C Laule-Kilian K Scholer A Perruchoud AP B-type natriuretic peptide for risk stratification in community-acquired pneumonia J Intern Med 2005, 258:391-393. 10.1111/j.1365-2796.2005.01540.x 16164581